Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
出版年份 2020 全文链接
标题
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
作者
关键词
Castration-resistant prostate cancer (CRPC), Androgen receptor (AR), AR-V7, NUP210, SLC3A2
出版物
Translational Oncology
Volume 14, Issue 1, Pages 100915
出版商
Elsevier BV
发表日期
2020-10-21
DOI
10.1016/j.tranon.2020.100915
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 Histone Tags Suggest Distinct Regulatory Evolution of Open and Condensed Chromatin Landmarks
- (2019) Anna A. Igolkina et al. Cells
- The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
- (2018) Rokaya El Ansari et al. BRITISH JOURNAL OF CANCER
- The potential of AR-V7 as a therapeutic target
- (2018) Takuma Uo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis
- (2018) Joana Borlido et al. NATURE IMMUNOLOGY
- Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import
- (2018) Veronica Rodriguez-Bravo et al. CELL
- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Epstein-Barr virus infection induces genome-wide de novo DNA methylation in non-neoplastic gastric epithelial cells
- (2017) Keisuke Matsusaka et al. JOURNAL OF PATHOLOGY
- SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway
- (2017) Bin Zhu et al. ONCOLOGY REPORTS
- Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus
- (2017) Atsushi Okabe et al. Scientific Reports
- Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells
- (2016) Minhui Xu et al. JOURNAL OF UROLOGY
- Extracellular Release of Annexin A2 is Enhanced upon Oxidative Stress Response via the p38 MAPK Pathway after Low-Dose X-Ray Irradiation
- (2016) Kazuko Kita et al. RADIATION RESEARCH
- TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection
- (2016) Hiroe Namba-Fukuyo et al. Oncotarget
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Clinical Relevance of Androgen Receptor Splice Variants in Castration-Resistant Prostate Cancer
- (2015) Benjamin L. Maughan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Nuclear pore proteins and the control of genome functions
- (2015) Arkaitz Ibarra et al. GENES & DEVELOPMENT
- The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells
- (2015) Ji Lu et al. JOURNAL OF UROLOGY
- Are androgen receptor variants a substitute for the full-length receptor?
- (2015) Ji Lu et al. Nature Reviews Urology
- CD98hc (SLC3A2) Loss Protects Against Ras-Driven Tumorigenesis by Modulating Integrin-Mediated Mechanotransduction
- (2014) S. Estrach et al. CANCER RESEARCH
- CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior
- (2013) Marina Poettler et al. Molecular Cancer
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
- (2012) B. Sahu et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal
- (2012) Siu Chiu Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- The Structure of the Nuclear Pore Complex
- (2011) André Hoelz et al. Annual Review of Biochemistry
- Identification and validation of genes involved in cervical tumourigenesis
- (2011) Thangarajan Rajkumar et al. BMC CANCER
- Activation of Bmp2-Smad1 Signal and Its Regulation by Coordinated Alteration of H3K27 Trimethylation in Ras-Induced Senescence
- (2011) Atsushi Kaneda et al. PLoS Genetics
- GREAT improves functional interpretation of cis-regulatory regions
- (2010) Cory Y McLean et al. NATURE BIOTECHNOLOGY
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started